Stay updated on Risankizumab in PsA Patients: Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in PsA Patients: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-25T06:49:48.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-10T15:33:16.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Minor website revision updates were made: Revision v3.4.2 was added and Revision v3.4.1 was removed. No user-facing content or study data were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-17T04:21:06.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed the previous notices (Revision: v3.4.0) related to government funding and operating status.
    Difference
    0.1%
    Check dated 2026-02-10T01:11:33.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top with links to cc.nih.gov and opm.gov, and added a 2025 Arthritis Research & Therapy article citation by Gossec et al. on risankizumab in PsA while removing the online-ahead-of-print note for that citation.
    Difference
    0.1%
    Check dated 2026-02-02T21:12:41.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Added a glossary display toggle; updated labels including 'Last Update Submitted that Met QC Criteria' capitalization and changed the No FEAR Act data phrasing, with the revision updated to v3.4.0.
    Difference
    0.1%
    Check dated 2026-01-26T19:37:39.000Z thumbnail image

Stay in the know with updates to Risankizumab in PsA Patients: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.